1546 related articles for article (PubMed ID: 16717206)
1. Revised diagnostic criteria for neuromyelitis optica.
Wingerchuk DM; Lennon VA; Pittock SJ; Lucchinetti CF; Weinshenker BG
Neurology; 2006 May; 66(10):1485-9. PubMed ID: 16717206
[TBL] [Abstract][Full Text] [Related]
2. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Lennon VA; Wingerchuk DM; Kryzer TJ; Pittock SJ; Lucchinetti CF; Fujihara K; Nakashima I; Weinshenker BG
Lancet; 2004 Dec 11-17; 364(9451):2106-12. PubMed ID: 15589308
[TBL] [Abstract][Full Text] [Related]
3. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
4. Brain abnormalities in neuromyelitis optica.
Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
[TBL] [Abstract][Full Text] [Related]
5. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.
Saiz A; Zuliani L; Blanco Y; Tavolato B; Giometto B; Graus F;
J Neurol; 2007 Sep; 254(9):1233-7. PubMed ID: 17401734
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
8. NMO-IgG: a specific biomarker for neuromyelitis optica.
Weinshenker BG; Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA
Dis Markers; 2006; 22(4):197-206. PubMed ID: 17124341
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica.
Wingerchuk DM
Int MS J; 2006 May; 13(2):42-50. PubMed ID: 16635421
[TBL] [Abstract][Full Text] [Related]
10. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of neuromyelitis optica.
Wingerchuk DM
Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
13. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
Harirchian MH; Tafakhori A; Taslimi S; Aghamollaii V; Shahsiah R; Gholipour T; Mohammadi F; Zare-Shahabadi A
Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):98-104. PubMed ID: 25530145
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
16. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
[TBL] [Abstract][Full Text] [Related]
17. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.
Rubiera M; Río J; Tintoré M; Nos C; Rovira A; Téllez N; Montalban X
Neurology; 2006 May; 66(10):1568-70. PubMed ID: 16717222
[TBL] [Abstract][Full Text] [Related]
19. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
20. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
